Pfizer’s earnings top expectations, but stock wavers as some key product sales disappoint

Pfizer stock rose early Tuesday as the drugmaker beat analysts’ earnings expectations and reaffirmed full-year 2024 guidance.

Pfizer’s earnings top expectations, but stock wavers as some key product sales disappoint
Pfizer stock rose early Tuesday as the drugmaker beat analysts’ earnings expectations and reaffirmed full-year 2024 guidance.